Financials • Accident &Health Insurance
$123.54 ▲ +1.79
(+1.47%)
MKT CAP: $61.94B • VOL: 1.54M
52W L $105 52W H $130
AFL // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.16B | $18.93B | $18.70B |
| YoY Revenue Growth % | -9.3% | +1.2% | — |
| Gross Profit | $7.55B | $8.33B | $8.23B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.30B | $6.42B | $5.50B |
| Operating Margin % | 25.1% | 33.9% | 29.4% |
| Net Income (GAAP) | $3.65B | $5.44B | $4.66B |
| EBITDA (Normalized) | $4.92B | $7.10B | $6.17B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.56B | $2.71B | $3.19B |
| Capital Expenditures (CapEx) | $772.4M | $851.7M | $841.5M |
| Free Cash Flow (FCF) | $1.78B | $1.86B | $2.35B |
| FCF Margin % | 10.4% | 9.8% | 12.6% |
| Return on Invested Capital (ROIC %) | 5.4% | 8.3% | 21.1% |
| Cash & Short-Term Equivalents | $6.25B | $6.23B | $3.75B |
| Total Debt (Short + Long Term) | $39.14B | $41.16B | $7.97B |
| Total Stockholders' Equity | $29.49B | $26.10B | $16.35B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AFL.